Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Yu Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3980-8133; OpenAlex author ID A5005670014. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery. Last author DOI 10.1002/ccs3.70033↗
  2. Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling. Last author DOI 10.1038/s41419-020-2595-9↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Su · 1 shared paper, 2025 · strength 0.33
  2. Huan Qin · 1 shared paper, 2025 · strength 0.33
  3. Xin Li · 1 shared paper, 2020 · strength 0.11
  4. Chenjing Wang · 1 shared paper, 2020 · strength 0.11
  5. Yunshan Wang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.